34 related articles for article (PubMed ID: 17255928)
1. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
3. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
4. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
[TBL] [Abstract][Full Text] [Related]
5. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women.
Hwang T
J Korean Med Sci; 1999 Dec; 14(6):593-9. PubMed ID: 10642935
[TBL] [Abstract][Full Text] [Related]
6. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
[TBL] [Abstract][Full Text] [Related]
7. Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
Sasaki Y; Iwanari O; Arakawa I; Moriya T; Mikami Y; Iihara K; Konno R
Int J Gynecol Cancer; 2017 Mar; 27(3):523-529. PubMed ID: 27997455
[TBL] [Abstract][Full Text] [Related]
8. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
9. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
10. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
11. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
12. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of HPV DNA testing in cervical cancer screening strategies.
Bhatla N; Moda N
Indian J Med Res; 2009 Sep; 130(3):261-5. PubMed ID: 19901435
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of HPV sequences detection in cervical carcinoma screening].
Noël JC; Bucella D; Fayt I; Romero-Munoz MR; Simon P
Ann Pathol; 2006 Oct; 26(5):389-96. PubMed ID: 17255928
[TBL] [Abstract][Full Text] [Related]
16. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
17. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.
Wright TC; Stoler MH; Parvu V; Yanson K; Cooper C; Andrews J
Gynecol Oncol; 2019 Aug; 154(2):360-367. PubMed ID: 31160073
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]